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o r i g i n a l a r t i c l e
Comparison of QuantiFERON-TB Gold In-Tube Test
and Tuberculin Skin Test for Identification of Latent Mycobacterium
tuberculosis Infection in Healthcare Staff and Association
Between Positive Test Results and Known Risk Factors for Infection
Paul Vinton, MBBS; Seema Mihrshahi, PhD; Paul Johnson, MBBS, PhD; Grant A. Jenkin, MBBS, PhD;
Damien Jolley, MSc; Beverley-Ann Biggs MBBS, PhD
objective. We compared a wholeblood interferon-g release assay (QuantiFERON-TB Gold In-Tube test, hereafter “QFT–in tube test”)
with a tuberculin skin test (TST) to determine which test more accurately identified latent Mycobacterium tuberculosis infection in healthcare
staff .
methods. A total of 481 hospital staff members were recruited from 5 hospitals in Melbourne, Australia. They provided information
about demographic variables and tuberculosis (TB) risk factors (ie, birth or travel in a country with a high prevalence of TB, working in
an occupation likely to involve contact with M. tuberculosis or individuals with TB, or being a household contact of an individual with a
proven case of pulmonary TB). The QFT–in tube test and the TST were administered in accordance with standardized protocols. Concordance
between the test results and positive risk factors was analyzed using the k statistic, the McNemar test, and logistic regression.
results. A total of 358 participants had both a TST result and a QFT–in tube test result available for comparison. There were fewer
positive QFT–in tube test results than positive TST results (6.7% vs. 33.0%; ). Agreement between the tests was poor (71%;P ! .001 kp
). A positive QFT–in tube test result was associated with birth in a country with a high prevalence of TB, the number of years an0.16
individual had lived in a country with a high prevalence of TB (ie, the effect of each additional year, treated as a continuous variable),
and high-risk occupational contact. A positive TST result was associated with older age, receipt of bacille Calmette-Gue´rin (BCG) vaccination,
and working in an occupation that involved patient contact. Receipt of BCG vaccination was most strongly associated with discordant
results in instances in which the TST result was positive and the QFT–in tube test result was negative.
conclusion. In a population of healthcare staff with a low prevalence of TB and a significant rate of BCG vaccination, a positive QFT–
in tube test result was associated with the presence of known risk factors for TB exposure, whereas a positive TST result was more strongly
associated with a prior history of BCG vaccination.
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The need for enhanced infection control and improved
screening and prevention programs for healthcare staff1 has
been increased by high rates of latent Mycobacterium tuber-
culosis infection (LTBI) among healthcare workers (HCWs)2-4
and the emergence of tuberculosis (TB) strains that are re-
sistant to all first-line anti-TB agents (so-called extensively
drug-resistant, or XDR, TB) and thus disease that has no
effective therapy and high mortality rates.5 Some advocate a
return to bacille Calmette-Gue´rin (BCG) vaccination as a
means of protection.6
Current screening methods for HCWs rely on the use of
the tuberculin skin test (TST).7 However, the usefulness of
the TST is limited by a lack of specificity when used to test
people with a history of BCG vaccination, the need for a
return visit to interpret the test result, and the subjectivity
involved in interpreting results.8,9 These problems are of con-
cern when testing groups with a low prevalence of TB and
high rates of BCG vaccination, such as HCWs in high-income
countries, and it is likely that a significant number of positive
TST results in this group are the result of prior BCG
vaccination.10-12
New diagnostic tests for LTBI that detect in vitro inter-
feron-g production in response to M. tuberculosis–specific
antigens eliminate the potential for false-positive results
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table 1. Characteristics of Study Participants Who
Underwent Tuberculosis Testing
Characteristic Value
Age, median (range), years 42 (20-66)
Sex
Female 431 (89.6)
Male 50 (10.4)
Occupation
Nurse 313 (65.1)
Physician 15 (3.1)
Allied health staff 47 (9.8)
Clerical staff 33 (6.9)
Patient services assistant 34 (7.1)
Other 39 (8.1)
BCG vaccination status
Vaccinated 375 (78.0)
Unvaccinated 78 (16.2)
Unknown 28 (5.8)
Country of birth
Australia 320 (66.5)
Low-prevalence country 64 (13.3)
Intermediate-prevalence country 39 (8.1)
High-prevalence country 58 (12.1)
Travel to a high-prevalence country
No 383 (79.6)
Yes 98 (20.4)
High-risk occupational exposure
No 420 (87.3)
Yes 61 (12.7)
Household contact of an individual with
a proven case of pulmonary TB
No 472 (98.1)
Yes 9 (1.9)
note. Data are no. (%) of participants, unless otherwise
specified. See Methods for details about risk categories. BCG,
bacille Calmette-Gue´rin; TB, tuberculosis.
caused by previous BCG vaccination.13,14 The QuantiFERON-
TB Gold In-Tube (Cellestis; hereafter “QFT–in tube”) is one
such test; it has been shown to be comparable to the TST in
terms of its sensitivity in detecting active disease and iden-
tifying infection among recent contacts of individuals with
TB.14,15 Evidence is still accumulating regarding its suitability
and sensitivity for occupational screening.16
In this study, we evaluated the QFT–in tube test by com-
paring it with the TST as a method for screening healthcare
staff for LTBI in metropolitan hospitals in Melbourne, Aus-
tralia, where the percentage of individuals with positive TST
results has previously been shown to be 20%.3 We used the
correlation between the 2 test results and the presence or
absence of known risk factors for TB exposure, as well as the
extent of such exposure, to determine which of the tests more
accurately detected latent infection.
methods
Recruitment
The study was conducted at 5 hospitals in the Southern
Health Care Network (Melbourne, Australia) and was ap-
proved by the Human Research Ethics Committees of Mel-
bourne Health and the Southern Health Care Network. All
hospital staff (physicians, nurses, allied health staff, patient
services assistants, and clerical staff) were invited to partic-
ipate in the study; enrollment was encouraged by use of post-
ers, public address system announcements, and ward visits,
with the assistance of each hospital’s infection prevention and
control unit. Staff members who were pregnant or who had
previously experienced severe reaction or allergy to purified
protein derivative were excluded from receiving the TST but
were eligible to undergo the QFT–in tube test. Staff who had
a previously documented positive TST result and did not wish
to have another TST were also eligible to undergo the QFT–
in tube test.
Assessment of Previous Exposure and Risk Factors
Information on age, sex, occupation, other illnesses, history
of past TST results, country of birth, date of arrival in Aus-
tralia, history and duration of overseas travel, and known
exposure to TB was collected via interviews. BCG vaccination
status was ascertained by self-reported vaccination history
and/or the detection of a BCG vaccination scar on visual
inspection by the interviewer; where possible, BCG vacci-
nation status was confirmed with previous staff vaccination
records. For each participant, the country of birth and the
locations of overseas travel were divided into the following
3 groups on the basis of published TB prevalence rates: high-
prevalence countries (x100 cases of TB per 100,000 popu-
lation), intermediate-prevalence countries (10-100 cases of
TB per 100,000 population), and low-prevalence countries
(!10 cases of TB per 100,000 population).17,18
We also defined 5 groups that were at high risk for exposure
to TB. In the absence of a “gold standard” diagnostic test for
LTBI, we used the risk of exposure to TB (defined by these
risk groups) as a proxy “gold standard” with which to com-
pare the 2 tests. These groups were as follows: (1) those born
in a high-prevalence country, (2) those with a lifetime history
of travel to a high-prevalence country for more than 12
months, (3) those whose occupation included a high likeli-
hood of TB contact (ie, work in a bronchoscopy suite, work
as a respiratory or infectious diseases physician, work on a
dedicated TB ward, microbiology or pathology work involv-
ing M. tuberculosis, or performance of autopsies), (4) those
with high-risk occupational contact (ie, more than 10 hours
total contact with a patient known to have TB, without re-
spiratory precautions), and (5) those who were household
contacts of an individual with a proven case of pulmonary
TB. An individual’s total number of risk factors and the du-
ration of time that person had lived in a high-prevalence
country were later used in our analysis as surrogate markers
for the extent of exposure.
TST
A “one-step” tuberculin strategy was chosen because this was
the strategy currently in use for TB screening in the Southern
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table 2. Results of QuantiFERON-TB Gold In-Tube Test (QFT–In Tube Test) and
Tuberculin Skin Test (TST), According to Bacille Calmette-Gue´rin (BCG) Vaccination
Status
BCG vaccinated Not BCG vaccinated
Positive
TST result
Negative
TST result
Positive
TST result
Negative
TST result
Positive QFT–in tube test result 16 4 0 1
Negative QFT–in tube test result 94 164 4 58
figure 1. Percentage of subjects with a positive QuantiFERON-
TB Gold In-Tube (QFT–in tube) test result, according to size of
tuberculin skin test (TST) induration.
Health Care Network. The TST was performed by use of the
Mantoux method, in accordance with Australian guidelines,19
which recommend 10 IU of purified protein derivative (Com-
monwealth Serum Laboratories); the test result was inter-
preted 48-72 hours after administration by use of the pal-
pation method. The test was performed by trained nursing
staff who were blinded to the results of the QFT–in tube test
and the questionnaire. A positive TST result was defined as
induration of 10 mm or greater.20
QFT–In Tube Test
The QuantiFERON-TB Gold assay, also referred to as the
“second-generation” QFT assay or QFT-2G, uses selected M.
tuberculosis antigens or peptide-simulating antigens, includ-
ing early secreted antigenic target 6 and culture filtrate protein
10 . A newer version of this assay, known as the Quanti-
FERON-TB Gold In-Tube test or “third-generation” QFT as-
say, was used for this study. This test involves the collection
of blood samples in tubes prefilled with antigen (typically a
negative control tube, an M. tuberculosis–antigen tube, and
an optional mitogen tube), which simplifies laboratory pro-
cedures.21 The QFT–in tube test was performed and results
interpreted in accordance with the manufacturer’s guide-
lines.22 Kits were purchased from the manufacturer (Cellestis)
and were processed at the Cellestis laboratory in Carnegie,
Australia.
Statistical Analysis
Statistical analysis was performed using Stata, version 8.0
(Stata). Concordance between the TST results and the QFT–
in tube test results was examined by use of the k statistic; k
values of less than 0.4 indicate poor agreement, values of 0.4-
0.75 indicate good agreement, and values greater than 0.75
indicate excellent agreement.23
We estimated the increase in the likelihood of a positive
test result for each unit of exposure to the risk factors defined
above and used matched-pair logistic regression to assess the
significance of the difference in the associations between the
tests. The McNemar test and multiple logistic regression anal-
ysis were used to determine which factors were significantly
associated with a positive result. A multinomial logistic model
was used to determine the factors associated with discordant
test results (using concordant results as the comparator). Re-
sults are reported as odds ratios (ORs) with 95% confidence
intervals (CIs).
results
A total of 481 hospital staff members participated in the study,
all of whom had a QFT–in tube test performed. The char-
acteristics of the study subjects are shown in Table 1. Of 481
participants, 32 (6.7%) had a positive QFT–in tube test result,
441 (91.7%) had a negative result, and 8 (1.6%) had an
indeterminate result.
A total of 364 participants (75.7%) had a TST performed
and interpreted during the study. Of these, 120 (33.0%) had
a positive test result when a cutoff of 10 mm induration was
used, 73 (20.0%) participants showed induration of 15 mm
or greater, and 39 (10.7%) showed induration of 20 mm or
greater. Four people had a severe reaction to purified protein
derivative that involved ulceration or blistering, requiring
treatment. One hundred seventeen (24.3%) of the partici-
pants did not have a TST result available; 61 (12.7%) had a
previously documented positive TST result and declined to
repeat the TST, 8 (1.7%) declined the TST on the basis of a
previous severe reaction, and 47 (9.8%) failed to have the
test result interpreted within 72 hours, despite repeated at-
tempts to contact them (1 additional participant did not have
a TST performed because of having recently received a mea-
sles-mumps-rubella vaccination, which can interfere with
TST results).
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table 3. Multivariate Logistic Regression Comparing Positive QuantiFERON-TB Gold In-Tube Test (QFT–In Tube Test) and
Tuberculin Skin Test (TST) Results With Risk Factors for Tuberculosis (TB)
Risk factor
Positive QFT–in tube
test result Positive TST result
OR (95% CI) P OR (95% CI) P
Older age, per each additional year 1.03 (0.98-1.08) .206 1.02 (0.99-1.05) .064
Female sex 0.36 (0.09-1.43) .149 0.81 (0.31-2.10) .672
Birth in a high-prevalence country 6.15 (2.00-18.9) .002a 0.89 (0.34-2.26) .808
Residence in a high-prevalence country, per each additional year 1.04 (1.01-1.08) .018a 1.04 (1.01-1.06) .003a
Travel to a high-prevalence country 1.13 (0.59-2.15) .702 1.11 (0.73-1.70) .637
112 months of travel in a high-prevalence country 1.01 (0.98-1.03) .451 1.02 (0.96-1.07) .523
Receipt of BCG vaccination 1.29 (0.21-7.90) .780 9.23 (2.51-33.9) .001a
Receipt of prior TST 1.43 (0.29-6.88) .657 1.76 (0.73-4.23) .209
Occupation involving patient contact 0.70 (0.22-2.16) .534 2.58 (1.23-5.40) .012a
High-risk occupation 1.15 (0.11-11.9) .907 1.47 (0.36-6.01) .588
Duration of high-risk occupation, per each additional year 1.05 (0.89-1.23) .552 1.04 (0.93-1.16) .454
High-risk occupational exposure 5.60 (1.42-22.0) .014a 1.96 (0.68-5.63) .209
Household contact of an individual with a proven case of pulmonary TB 3.26 (0.25-41.6) .364 1.68 (0.20-13.9) .628
note. See Methods for details about risk categories. BCG, bacille Calmette-Gue´rin; CI, confidence interval; OR, odds ratio.
a Statistically significant ( ).P ! .05
figure 2. Relationship between positive results for the
QuantiFERON-TB Gold In-Tube test (QFT–in tube) and the tu-
berculin skin test (TST) and an individual’s total number of risk
factors. Error bars indicate 95% confidence intervals. OR, odds ratio.
Of the 364 participants who had TST results available, 6
had an indeterminate QFT–in tube test result; therefore, the
final sample size for comparison of the tests was 358 partic-
ipants. Table 2 shows the test results stratified by BCG vac-
cination status. The results analyzed below include only par-
ticipants who had results available for both tests.
Agreement Between the Test Results
There were fewer positive QFT–in tube test results than pos-
itive TST results (6.7% versus 33.0%; OR, 19.6 [95% CI, 8.6-
54.]; ). Five subjects with positive QFT–in tube testP ! .001
results had negative TST results. The agreement between the
QFT–in tube test and the TST was generally poor (71% when
a cutoff of 10 mm induration was used; ), but itkp 0.16
improved slightly when higher cutoff points were used for
the TST (82% for a cutoff of 15 mm induration [ ]kp 0.23
and 89% for a cutoff of 20 mm induration [ ]).kp 0.25
Agreement for tests of unvaccinated subjects was 92% when
a cutoff of 10 mm induration was used (kp 0.03
) and 97% when a cutoff of 15 mm induration was used (
kp 0.02
); agreement for tests of BCG-vaccinated subjects at the same
cutoff points was 66% ( ) and 79% ( ), re-kp 0.15 kp 0.22
spectively. For each 5-mm increase in induration, an increas-
ing proportion of subjects had a positive QFT–in tube test
result (Figure 1).
Correlation with Risk Factors
Table 3 shows the odds ratio for a positive QFT–in tube test
result relative to various exposures. The factors associated
with a positive QFT–in tube test result were birth in a high-
prevalence country, the number of years an individual had
lived in a high-prevalence country, and high-risk occupational
contact.
For the TST, receipt of BCG vaccination, an occupation
involving patient contact (as opposed to hospital occupations
that do not involve such contact, eg, clerical positions), and
a greater number of years lived in a high-prevalence country
were associated with a positive test result. Staff who reported
having had a previous TST were more likely to have a positive
result for the TST administered as part of this study (P !
) and staff whose occupation involved patient contact.001
were more likely to report a history of previous TST (P !
)..001
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table 4. Results of Multinomial Logistic Regression for Discordant QuantiFERON-TB Gold In-Tube Test (QFT–In Tube Test)
and Tuberculin Skin Test (TST) Results
Risk factor
Positive QFT–in tube
test result and negative
TST result
Positive TST result and
negative QFT–in tube
test result
OR (95% CI) P OR (95% CI) P
Older age, per each additional year 1.01 (0.90-1.14) .813 1.02 (0.99-1.04) .112
Female sex 0.21 (0.01-5.36) .343 0.76 (0.30-1.95) .574
Birth in a high-prevalence country 22.5 (0.92-549) .057 0.49 (0.17-1.36) .171
Residence in a high-prevalence country, per each additional year 1.01 (0.91-1.11) .878 1.01 (0.99-1.04) .132
Travel to a high-prevalence country 1.44 (0.13-15.7) .767 0.93 (0.61-1.42) .747
112 months of travel in a high-prevalence country 0.35 (0.03-4.09) .402 1.01 (0.97-1.06) .460
Receipt of BCG vaccination 2.44 (0.06-105) .641 7.11 (2.04-24.7) .002a
Receipt of prior TST 0.56 (0.04-8.63) .681 1.63 (0.65-4.10) .298
Occupation involving patient contact 0.97 (0.07-14.7) .998 3.96 (1.74-9.02) .001a
High-risk occupation 23.2 (0.26-2003) .169 1.30 (0.31-5.45) .718
Duration of high-risk occupation, per each additional year 0.35 (0.03-4.01) .400 1.00 (0.89-1.11) .979
High-risk occupational exposure 31.1 (1.30-746) .034a 1.89 (0.67-5.35) .230
Household contact of an individual with a proven case of pulmonary TB 3.66 (0.06-238) .543 1.69 (0.20-14.1) .627
note. See Methods for details about risk categories. BCG, bacille Calmette-Gue´rin; CI, confidence interval; OR, odds ratio; TB, tuberculosis.
a Statistically significant ( ).P ! .05
figure 3. Relationship between positive results for the
QuantiFERON-TB Gold In-Tube test (QFT–in tube) and the tu-
berculin skin test (TST) and the number of years participants had
lived in a high-prevalence country. Error bars indicate 95% confi-
dence intervals. OR, odds ratio.
The results of a multinomial logistic regression for dis-
cordant results are shown in Table 4. High-risk occupational
contact and birth in a high-prevalence country showed the
strongest association with discordant test results in instances
in which the QFT–in tube test result was positive and the
TST result was negative. Receipt of BCG vaccination and
having an occupation that involved patient contact were most
strongly associated with discordant results in instances in
which the TST result was positive and the QFT–in tube test
result was negative.
Correlation With Extent of Exposure
The relationship between positive results for each test and an
individual’s total number of risk factors is shown in Figure
2, and the relationship between positive test results and the
number of years participants had lived in a high-prevalence
country is shown in Figure 3. A positive QFT–in tube test
result correlated with increased exposure for both the number
of years individuals lived in a high-prevalence country (OR,
1.5 [95% CI, 1.16-1.92]; ) and their total numberPp .002
of risk factors (OR, 2.7 [95% CI, 1.49-4.71]; ). In-Pp .001
creased exposure as measured by duration of travel in a high-
prevalence country or time worked in a high-risk occupation
was not significantly associated with positive results for either
test.
discussion
To our knowledge, this is the largest study to date that com-
pares the QFT–in tube test and the TST for screening health-
care staff in a developed country, and the first to correlate
findings with the extent of exposure to known risk factors.
The findings demonstrate that in a population with a low
prevalence of TB but a significant rate of BCG vaccination,
a positive QFT–in tube test result has a stronger degree of
association with the presence of known risk factors for TB
exposure than does a positive TST result, whereas a positive
TST result has a strong association with a prior history of
BCG vaccination (OR, 9.23) and some risk factors for TB.
The findings support the hypothesis that BCG vaccination
status may significantly affect the proportion of positive TST
results and suggest that the QFT–in tube test may be more
effective for identifying HCWs with LTBI in countries with
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a low prevalence of TB by eliminating the possibility of false-
positive results caused by BCG vaccination.
Our results are consistent with those of a Korean study24
that showed the QFT–in tube test to be comparable with the
TST in its ability to detect LTBI and showed QFT–in tube
test results to be less affected by BCG vaccination status; our
results are also consistent with those of a Japanese study25 in
which HCWs in a community hospital were assigned a con-
tact score on the basis of their contact time with an index
patient with TB and the infectivity of the index patient. In
that study, the QFT–in tube test result showed a better as-
sociation with the contact score than did the TST result.
Our findings are contrary to those of a study conducted
in India in which there was good agreement ( ) be-kp 0.61
tween the QFT–in tube test result and the TST result for
HCWs.26 The differences between their findings and ours
could be explained by the differing prevalence of exposure
to TB in the 2 study populations. If both tests are of com-
parable sensitivity, the level of agreement between the tests
is likely to increase as the TB prevalence (and therefore the
number of true-positive results) in a population increases.
Agreement would, therefore, be lower in low-prevalence pop-
ulations with a comparable proportion of confounding fac-
tors, such as BCG vaccination, that might influence the result
of one test (the TST) but not the other (the QFT–in tube
test). The high level of agreement between the tests for Indian
HCWs also provides indirect evidence that the QFT–in tube
test may have a sensitivity similar to that of the TST.
Our findings are also contrary to those of a study of US
military personnel that found discordant results to be asso-
ciated with birth in a high-prevalence country. The authors
of that study concluded that the QFT–in tube test was more
specific than the TST when a cutoff of 10 mm induration is
used, but also that it may not be as sensitive for the detection
of TB as a properly performed TST.27 In our study, not only
did a positive QFT–in tube test result show a stronger cor-
relation than a positive TST result with birth in a high-prev-
alence country, but this factor was also associated with dis-
cordant results in instances in which the TST result was
negative. The QFT–in tube test result also showed a stronger
correlation with the number of years individuals had lived
in a high-prevalence country when this was used as a marker
for the extent of exposure. The odds of a positive TST result
appeared to plateau after 20 years spent living in a high-
prevalence country, whereas the odds of a positive QFT–in
tube test result continued to rise after that point. This latter
finding may be of relevance to the study by Mazurek et al.,27
in which the mean age of participants was only 20 years.
A limitation of the present study was the high rate of loss
to follow-up; 117 (24.3%) of the 481 participants originally
recruited did not have a TST performed and/or a TST result
interpreted, and a large proportion of these individuals had
had positive TST results in the past. Therefore, the possibility
of selection bias cannot be excluded. Our study was further
limited by the fact that some subcategories contained a only
small number of subjects, which may have prevented some
relationships from becoming fully apparent in our analysis
A number of different strategies have been suggested for
LTBI screening of HCWs, including the use of a 2-stage testing
strategy, in which an initial TST is followed by a QFT–in
tube test for those with a positive TST result.28 Our findings
suggest that this approach may fail to identify a significant
proportion of individuals who may have a negative TST result
but would have a positive QFT–in tube test result if tested.
Although a strategy that combines the use of both the TST
and the QFT–in tube test may be appropriate for patients at
high risk for TB reactivation (such as immunosuppressed
individuals), implementing this strategy for a low-risk group
such as HCWs would result in increased cost without re-
ducing any of the inherent problems of TST testing.
Our findings support the recent Centers for Disease Con-
trol and Prevention guidelines, which suggest that the QFT–
in tube test is a viable alternative for a widespread HCW
screening program.13,29 If this approach were used, it is likely
that far fewer staff would require follow-up and treatment,
which has significant implications for reducing the costs of
a screening program, as well as for reducing the morbidity
that results from adverse reactions to isoniazid therapy.
acknowledgments
We thank the participating healthcare workers; Drs. Alan Street, Tony Kor-
man and Jim Black for discussions about the study; the Infection Control
Unit at Southern Health and Mr. Francis Tyler for assistance with recruitment
and performance of tuberculin skin tests; and Christalla Hajisava for assis-
tance with the manuscript.
Financial support: Department of Human Services Victoria (Public
Health Research Projects grant to B.-A.B.); National Health and Medical
Research Council (scholarship to P.V.); Edgar Tattnall Memorial Trust (grant
to B.-A.B.).
Potential conflicts of interest: Cellestis is a listed Australian Security and
supplied the QuantiFERON-TB Gold In-Tube test kits for the study. Cellestis
personnel did not participate in study design, data analysis, or manuscript
preparation. None of the authors are holders of Cellestis stock. G.A.J. and
D.J. have received study support from Cellestis.
Address reprint requests to Beverley-Ann Biggs, MBBS, PhD, Department
of Medicine (RMH/WH), the University of Melbourne, the Royal Melbourne
Hospital, Parkville 3050, Australia (babiggs@unimelb.edu.au); or Seema
Mihrshahi, PhD, Department of Medicine (RMH/WH), the University of
Melbourne, the Royal Melbourne Hospital, Parkville 3050, Australia
(seemam@unimelb.edu.au).
references
1. Jereb JA, Klevens RM, Privett TD, et al. Tuberculosis in health care
workers at a hospital with an outbreak of multidrug-resistant Mycobac-
terium tuberculosis. Arch Intern Med 1995; 155:854-859.
2. Menzies D, Joshi R, Pai M. Risk of tuberculosis infection and disease
associated with work in health care settings. Int J Tuberc Lung Dis
2007; 11:593-605.
3. Stuart RL, Bennett NJ, Forbes AB, Grayson ML. Assessing the risk of
tuberculosis infection among healthcare workers: the Melbourne Man-
toux Study. Melbourne Mantoux Study Group. Med J Aust 2001; 174:
569-573.
This content downloaded from 23.235.32.0 on Wed, 21 Oct 2015 22:24:53 PM
All use subject to JSTOR Terms and Conditions
identification of latent tb in healthcare workers 221
4. Stuart RL, Grayson ML. Health care workers and tuberculosis. Aust N
Z J Med 2000; 30:367-372.
5. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuber-
culosis as a cause of death in patients co-infected with tuberculosis and
HIV in a rural area of South Africa. Lancet 2006; 368:1575-1580.
6. Graham M, Howley TM, Pierce RJ, Johnson PD. Should medical students
be routinely offered BCG vaccination? Med J Aust 2006; 185:324-326.
7. Moran-Mendoza O, Marion SA, Elwood K, Patrick DM, FitzGerald JM.
Tuberculin skin test size and risk of tuberculosis development: a large
population-based study in contacts. Int J Tuberc Lung Dis 2007; 11:1014-
1020.
8. Tissot F, Zanetti G, Francioli P, Zellweger JP, Zysset F. Influence of bacille
Calmette-Guerin vaccination on size of tuberculin skin test reaction: to
what size? Clin Infect Dis 2005; 40:211-217.
9. von Reyn CF, Horsburgh CR, Olivier KN, et al. Skin test reactions to
Mycobacterium tuberculosis purified protein derivative and Mycobacte-
rium avium sensitin among health care workers and medical students in
the United States. Int J Tuberc Lung Dis 2001; 5:1122-1128.
10. Panlilio AL, Burwen DR, Curtis AB, et al. Tuberculin skin testing sur-
veillance of health care personnel. Clin Infect Dis 2002; 35:219-227.
11. Marsh BJ, San Vicente J, von Reyn CF. Utility of dual skin tests to evaluate
tuberculin skin test reactions of 10 to 14 mm in healthcare workers.
Infect Control Hosp Epidemiol 2003; 24:821-824.
12. Johnson PD, Stuart RL, Grayson ML, et al. Tuberculin-purified protein
derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon re-
sponses in medical students before and after Mycobacterium bovis BCG
vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol
1999; 6:934-937.
13. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A.
Guidelines for using the QuantiFERON-TB Gold test for detecting My-
cobacterium tuberculosis infection, United States. MMWR Recomm Rep
2005; 54(RR-15):49-55.
14. Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the im-
munodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis
2004; 4:761-776.
15. Nakaoka H, Lawson L, Squire SB, et al. Risk for tuberculosis among
children. Emerg Infect Dis 2006; 12:1383-1388.
16. Villarino ME, Mazurek G. Tuberculosis contacts, concerns, and controls:
what matters for healthcare workers? Infect Control Hosp Epidemiol
2006; 27:433-435.
17. World Health Organization. Global Tuberculosis Database 2006. Avail-
able at: http://www.who.int/globalatlas/dataQuery/default.asp. Accessed
November 12, 2007.
18. Broekmans JF, Migliori GB, Rieder HL, et al. European framework for
tuberculosis control and elimination in countries with a low incidence:
recommendations of the World Health Organization (WHO), Interna-
tional Union against Tuberculosis and Lung Disease (IUATLD) and Royal
Netherlands Tuberculosis Association (KNCV) Working Group. Eur Res-
pir J 2002; 19:765-775.
19. The Australian immunisation handbook. 9th ed. Australia: National
Health Medical Research Council; 2008:231-234. Available at: http:
//www.immunise.health.gov.au/internet/immunise/publishing.nsf/Con
tent/Handbookhome. Accessed January 14, 2009.
20. Department of Human Services. Management, control and prevention
of tuberculosis: guidelines for health care providers (2002-2005). Avail-
able at:http://www.health.vic.gov.au/ideas/diseases/tb_mgmt_guide. Ac-
cessed January 14, 2009.
21. Farris A, Branda J. QuantiFERON-TB Gold assay for tuberculosis in-
fection. Clin Microbiol Newsl 2007;129-136.
22. Cellestis. QuantiFERON-TB Gold IT Method and Technical Instructions.
Melbourne, Australia: Cellestis; 2007. Available at: http://www.cellestis
.com/IRM/Content/aust/qtfproducts_tbgoldintube_techinfo.html. Ac-
cessed December 12, 2007.
23. Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with
tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection
in a school tuberculosis outbreak. Lancet 2003; 361:1168-1173.
24. Kang YA, Lee HW, Yoon HI, et al. Discrepancy between the tuberculin
skin test and the whole-blood interferon gamma assay for the diagnosis
of latent tuberculosis infection in an intermediate tuberculosis-burden
country. JAMA 2005; 293:2756-2761.
25. Kobashi Y, Obase Y, Fukuda M, et al. Usefulness of QuantiFERON TB-
2G, a diagnostic method for latent tuberculosis infection, in a contact
investigation of health care workers. Intern Med (Tokyo, Japan). 2007; 46:
1543-1549.
26. Pai M, Gokhale K, Joshi R, et al. Mycobacterium tuberculosis infection
in health care workers in rural India: comparison of a whole-blood
interferon gamma assay with tuberculin skin testing. JAMA 2005; 293:
2746-2755.
27. Mazurek GH, Zajdowicz MJ, Hankinson AL, et al. Detection of Myco-
bacterium tuberculosis infection in United States Navy recruits using the
tuberculin skin test or whole-blood interferon-g release assays. Clin Infect
Dis 2007; 45:826-836.
28. Diel R, Nienhaus A, Lange C, Schaberg T. Cost-optimisation of screening
for latent tuberculosis in close contacts. Eur Respir J 2006; 28:35-44.
29. Jensen PA, Lambert LA, Iademarco MF, Ridzon R. Guidelines for pre-
venting the transmission of Mycobacterium tuberculosis in health-care
settings, 2005. MMWR Recomm Rep 2005; 54(RR-17):1-141.
This content downloaded from 23.235.32.0 on Wed, 21 Oct 2015 22:24:53 PM
All use subject to JSTOR Terms and Conditions
